3750

Cytori Cell Research Institute
3750

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
¥7.70B
EV
¥10.09B
Shares Outstanding
8.93M
Beta
0.09

Wall Street View

Analyst Rating
NOT_AVAILABLE
Analyst Target Price
-
P/E 2026E
-
P/Revenue 2026E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Cytori Cell Research Institute, Inc.

gainify
3750

Cytori Cell Research Institute, Inc.

3750

Cytori Cell Research Institute, Inc., engages in the research, development, production, and sale of cell therapy related medical devices in Japan. The company sells cell therapy kits, as well as engages in the research and development of cell therapy technology, etc. ...

Sector

Healthcare

Industry

Biotechnology

CEO

Hoshino, Yoshihiro

Employees

16

IPO Date

2001-01-01

Headquarters

Otemachi Park Building, 1-1-1 Otemachi, 7th floor, Chiyoda-ku, Tokyo 100-0004, Japan

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.